Regulation of the anti-tumour immune response by cancer-associated fibroblasts

Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 Kuperwasser, 2004, Reconstruction of functionally normal and malignant human breast tissues in mice, PNAS, 101, 4966, 10.1073/pnas.0401064101 Byzova, 2000, A mechanism for modulation of cellular responses to VEGF: activation of the integrins, Mol Cell, 6, 851 Berking, 2001, Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling, Cancer Res, 61, 8306 Fukumura, 1998, Tumor induction of VEGF promoter activity in stromal cells, Cell, 94, 715, 10.1016/S0092-8674(00)81731-6 Cornil, 1991, Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression, PNAS, 88, 6028, 10.1073/pnas.88.14.6028 Goh, 2007, Molecular and cellular regulators of cancer angiogenesis, Curr Cancer Drug Targets, 7, 743, 10.2174/156800907783220462 Servais, 2013, From sentinel cells to inflammatory culprits: cancer-associated fibroblasts in tumour-related inflammation, J Pathol, 229, 198, 10.1002/path.4103 Gaggioli, 2007, Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells, Nat Cell Biol, 9, 1392, 10.1038/ncb1658 Barclay, 2008, Characterization of adult prostatic progenitor/stem cells exhibiting self-renewal and multilineage differentiation, Stem Cells, 26, 600, 10.1634/stemcells.2007-0309 Morrison, 2008, Stem cells and niches: mechanisms that promote stem cell maintenance throughout life, Cell, 132, 598, 10.1016/j.cell.2008.01.038 Pavlides, 2010, Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the reverse Warburg effect: a transcriptional informatics analysis with validation, Cell Cycle, 9, 2201, 10.4161/cc.9.11.11848 Dvorak, 1986, Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing, N Engl J Med, 315, 1650, 10.1056/NEJM198612253152606 Feig, 2012, The pancreas cancer microenvironment, Clin Cancer Res, 18, 4266, 10.1158/1078-0432.CCR-11-3114 Tripathi, 2012, Understanding the role of stromal fibroblasts in cancer progression, Cell Adhes Migr, 6, 231, 10.4161/cam.20419 Kraman, 2010, Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha, Science, 330, 827, 10.1126/science.1195300 Saigusa, 2011, Cancer-associated fibroblasts correlate with poor prognosis in rectal cancer after chemoradiotherapy, Int J Oncol, 38, 655, 10.3892/ijo.2011.906 Kurose, 2002, Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas, Nat Genet, 32, 355, 10.1038/ng1013 Direkze, 2006, Bone marrow and tumour stroma: an intimate relationship, Hematol Oncol, 24, 189, 10.1002/hon.788 Direkze, 2004, Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts, Cancer Res, 64, 8492, 10.1158/0008-5472.CAN-04-1708 Mishra, 2008, Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells, Cancer Res, 68, 4331, 10.1158/0008-5472.CAN-08-0943 Forino, 2006, TGFbeta1 induces epithelial-mesenchymal transition, but not myofibroblast transdifferentiation of human kidney tubular epithelial cells in primary culture, Int J Exp Pathol, 87, 197, 10.1111/j.1365-2613.2006.00479.x Zeisberg, 2007, Endothelial-to-mesenchymal transition contributes to cardiac fibrosis, Nat Med, 13, 952, 10.1038/nm1613 Potenta, 2008, The role of endothelial-to-mesenchymal transition in cancer progression, Br J Cancer, 99, 1375, 10.1038/sj.bjc.6604662 Jotzu, 2010, Adipose tissue-derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor-derived factors, Anal Cell Pathol (Amst), 33, 61, 10.1155/2010/695162 Loeffler, 2006, Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake, J Clin Invest, 116, 1955, 10.1172/JCI26532 Sugimoto, 2006, Identification of fibroblast heterogeneity in the tumor microenvironment, Cancer Biol Ther, 5, 1640, 10.4161/cbt.5.12.3354 True, 2010, CD90/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarker, Mod Pathol, 23, 1346, 10.1038/modpathol.2010.122 Kalluri, 2006, Fibroblasts in cancer, Nat Rev Cancer, 6, 392, 10.1038/nrc1877 De Wever, 2008, Stromal myofibroblasts are drivers of invasive cancer growth, Int J Cancer, 123, 2229, 10.1002/ijc.23925 Vicent, 2012, Cross-species functional analysis of cancer-associated fibroblasts identifies a critical role for CLCF1 and IL-6 in non-small cell lung cancer in vivo, Cancer Res, 72, 5744, 10.1158/0008-5472.CAN-12-1097 Orimo, 2005, Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion, Cell, 121, 335, 10.1016/j.cell.2005.02.034 Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9 Buckley, 2001, Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation, Trends Immunol, 22, 199, 10.1016/S1471-4906(01)01863-4 Smith, 1997, Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation, Am J Pathol, 151, 317 Werner, 2003, Regulation of wound healing by growth factors and cytokines, Physiol Rev, 83, 835, 10.1152/physrev.2003.83.3.835 Aggarwal, 2009, Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe, Clin Cancer Res, 15, 425, 10.1158/1078-0432.CCR-08-0149 Grivennikov, 2010, Immunity, inflammation, and cancer, Cell, 140, 883, 10.1016/j.cell.2010.01.025 Peggs, 2008, Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy, Immunol Rev, 224, 141, 10.1111/j.1600-065X.2008.00649.x Loose, 2009, The immune system and cancer, Cancer Biother Radiopharm, 24, 369, 10.1089/cbr.2008.0593 Herrera, 2013, Cancer-associated fibroblast and M2 macrophage markers together predict outcome in colorectal cancer patients, Cancer Sci, 104, 437, 10.1111/cas.12096 Jung, 2010, Tumor-stromal crosstalk in invasion of oral squamous cell carcinoma: a pivotal role of CCL7, Int J Cancer, 127, 332 Acharyya, 2012, A CXCL1 paracrine network links cancer chemoresistance and metastasis, Cell, 150, 165, 10.1016/j.cell.2012.04.042 De Boeck, 2013, Differential secretome analysis of cancer-associated fibroblasts and bone marrow-derived precursors to identify microenvironmental regulators of colon cancer progression, Proteomics, 13, 379, 10.1002/pmic.201200179 Comito, 2013, Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression, Oncogene, 10.1038/onc.2013.191 Tjomsland, 2011, Interleukin 1alpha sustains the expression of inflammatory factors in human pancreatic cancer microenvironment by targeting cancer-associated fibroblasts, Neoplasia, 13, 664, 10.1593/neo.11332 Roca, 2009, CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization, J Biol Chem, 284, 34342, 10.1074/jbc.M109.042671 Wu, 2011, Targeting galectin-1 in carcinoma-associated fibroblasts inhibits oral squamous cell carcinoma metastasis by downregulating MCP-1/CCL2 expression, Clin Cancer Res, 17, 1306, 10.1158/1078-0432.CCR-10-1824 Lin, 2012, Cancer-associated fibroblasts up-regulate CCL2, CCL26, IL6 and LOXL2 genes related to promotion of cancer progression in hepatocellular carcinoma cells, Biomed Pharmacother, 66, 525, 10.1016/j.biopha.2012.02.001 Yoshimura, 2013, Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells, PLoS One, 8, e58791, 10.1371/journal.pone.0058791 Khazaie, 2011, The significant role of mast cells in cancer, Cancer Metastasis Rev, 30, 45, 10.1007/s10555-011-9286-z Crivellato, 2008, Mast cells and tumour angiogenesis: new insight from experimental carcinogenesis, Cancer Lett, 269, 1, 10.1016/j.canlet.2008.03.031 Ma, 2013, Dynamic mast cell-stromal cell interactions promote growth of pancreatic cancer, Cancer Res, 73, 3927, 10.1158/0008-5472.CAN-12-4479 Konno, 2011, Role of osteopontin, a multifunctional protein, in allergy and asthma, Clin Exp Allergy, 41, 1360, 10.1111/j.1365-2222.2011.03775.x Sun, 2013, Osteopontin splice variants expressed by breast tumors regulate monocyte activation via MCP-1 and TGF-beta1, Cell Mol Immunol, 10, 176, 10.1038/cmi.2012.67 Balsamo, 2009, Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity, PNAS, 106, 20847, 10.1073/pnas.0906481106 Erez, 2010, Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner, Cancer Cell, 17, 135, 10.1016/j.ccr.2009.12.041 Dienz, 2009, The effects of IL-6 on CD4 T cell responses, Clin Immunol, 130, 27, 10.1016/j.clim.2008.08.018 De Monte, 2011, Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer, J Exp Med, 208, 469, 10.1084/jem.20101876 Liao, 2009, Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model, PLoS One, 4, e7965, 10.1371/journal.pone.0007965 Tran, 2013, Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia, J Exp Med, 210, 1125, 10.1084/jem.20130110 Anderson, 2000, The angiogenic factor interleukin 8 is induced in non-small cell lung cancer/pulmonary fibroblast cocultures, Cancer Res, 60, 269 Baratelli, 2005, Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells, J Immunol, 175, 1483, 10.4049/jimmunol.175.3.1483 Groeger, 2010, Cyclooxygenase-2 generates anti-inflammatory mediators from omega−3 fatty acids, Nat Chem Biol, 6, 433, 10.1038/nchembio.367 Pena, 2013, STC1 expression by cancer-associated fibroblasts drives metastasis of colorectal cancer, Cancer Res, 73, 1287, 10.1158/0008-5472.CAN-12-1875 Wang, 2009, Stanniocalcin-1 suppresses superoxide generation in macrophages through induction of mitochondrial UCP2, J Leukoc Biol, 86, 981, 10.1189/jlb.0708454 Chakraborty, 2007, Stanniocalcin-1 regulates endothelial gene expression and modulates transendothelial migration of leukocytes, Am J Physiol Renal Physiol, 292, F895, 10.1152/ajprenal.00219.2006 Byrne, 2008, TGFbeta is responsible for skin tumour infiltration by macrophages enabling the tumours to escape immune destruction, Immunol Cell Biol, 86, 92, 10.1038/sj.icb.7100116 Shangguan, 2012, Inhibition of TGF-beta/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects, Stem Cells, 30, 2810, 10.1002/stem.1251 Kojima, 2010, Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts, PNAS, 107, 20009, 10.1073/pnas.1013805107 Nazareth, 2007, Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells, J Immunol, 178, 5552, 10.4049/jimmunol.178.9.5552 Laouar, 2005, Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma, Nat Immunol, 6, 600, 10.1038/ni1197 Weber, 2005, Transforming growth factor-beta1 immobilises dendritic cells within skin tumours and facilitates tumour escape from the immune system, Cancer Immunol Immunother, 54, 898, 10.1007/s00262-004-0652-3 Halliday, 2001, Transforming growth factor-beta produced by progressor tumors inhibits, while IL-10 produced by regressor tumors enhances, Langerhans cell migration from skin, Int Immunol, 13, 1147, 10.1093/intimm/13.9.1147 Bekeredjian-Ding, 2009, Tumour-derived prostaglandin E and transforming growth factor-beta synergize to inhibit plasmacytoid dendritic cell-derived interferon-alpha, Immunology, 128, 439, 10.1111/j.1365-2567.2009.03134.x Zhang, 2006, Blockade of transforming growth factor-{beta} signaling in tumor-reactive CD8(+) T cells activates the antitumor immune response cycle, Mol Cancer Ther, 5, 1733, 10.1158/1535-7163.MCT-06-0109 Sanjabi, 2009, Opposing effects of TGF-beta and IL-15 cytokines control the number of short-lived effector CD8+ T cells, Immunity, 31, 131, 10.1016/j.immuni.2009.04.020 Thomas, 2005, TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance, Cancer Cell, 8, 369, 10.1016/j.ccr.2005.10.012 Ahmadzadeh, 2005, TGF-beta 1 attenuates the acquisition and expression of effector function by tumor antigen-specific human memory CD8 T cells, J Immunol, 174, 5215, 10.4049/jimmunol.174.9.5215 Fantini, 2004, Cutting edge: TGF-beta induces a regulatory phenotype in CD4+ CD25-T cells through Foxp3 induction and down-regulation of Smad7, J Immunol, 172, 5149, 10.4049/jimmunol.172.9.5149 Shafer-Weaver, 2009, Cutting Edge: tumor-specific CD8+ T cells infiltrating prostatic tumors are induced to become suppressor cells, J Immunol, 183, 4848, 10.4049/jimmunol.0900848 Han, 2009, CD69+ CD4+ CD25-T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1, J Immunol, 182, 111, 10.4049/jimmunol.182.1.111 Kinoshita, 2013, Forkhead box P3 regulatory T cells coexisting with cancer associated fibroblasts are correlated with a poor outcome in lung adenocarcinoma, Cancer Sci, 104, 409, 10.1111/cas.12099 Levental, 2009, Matrix crosslinking forces tumor progression by enhancing integrin signaling, Cell, 139, 891, 10.1016/j.cell.2009.10.027 Lopez, 2011, In situ force mapping of mammary gland transformation, Integr Biol (Camb), 3, 910, 10.1039/c1ib00043h Cox, 2011, Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer, Dis Model Mech, 4, 165, 10.1242/dmm.004077 Lu, 2012, The extracellular matrix: a dynamic niche in cancer progression, J Cell Biol, 196, 395, 10.1083/jcb.201102147 Egeblad, 2010, Dynamic interplay between the collagen scaffold and tumor evolution, Curr Opin Cell Biol, 22, 697, 10.1016/j.ceb.2010.08.015 Olive, 2009, Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer, Science, 324, 1457, 10.1126/science.1171362 Morwood, 2006, Modulation of the immune response by extracellular matrix proteins, Arch Immunol Ther Exp (Warsz), 54, 367, 10.1007/s00005-006-0043-x Sorokin, 2010, The impact of the extracellular matrix on inflammation, Nat Rev Immunol, 10, 712, 10.1038/nri2852 Kobayashi, 2010, Hyaluronan deficiency in tumor stroma impairs macrophage trafficking and tumor neovascularization, Cancer Res, 70, 7073, 10.1158/0008-5472.CAN-09-4687 Ostman, 2004, PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma, Cytokine Growth Factor Rev, 15, 275, 10.1016/j.cytogfr.2004.03.002 Falcon, 2011, Increased vascular delivery and efficacy of chemotherapy after inhibition of platelet-derived growth factor-B, Am J Pathol, 178, 2920, 10.1016/j.ajpath.2011.02.019 Pietras, 2001, Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors, Cancer Res, 61, 2929 Pietras, 2002, Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy, Cancer Res, 62, 5476 Palazon, 2012, Molecular pathways: hypoxia response in immune cells fighting or promoting cancer, Clin Cancer Res, 18, 1207, 10.1158/1078-0432.CCR-11-1591 Hamzah, 2008, Vascular normalization in Rgs5-deficient tumours promotes immune destruction, Nature, 453, 410, 10.1038/nature06868 Rolny, 2011, HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF, Cancer Cell, 19, 31, 10.1016/j.ccr.2010.11.009 Ohm, 2003, VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression, Blood, 101, 4878, 10.1182/blood-2002-07-1956 Wada, 2009, The contribution of vascular endothelial growth factor to the induction of regulatory T-cells in malignant effusions, Anticancer Res, 29, 881 Lukashev, 2006, Cutting edge: hypoxia-inducible factor 1alpha and its activation-inducible short isoform I.1 negatively regulate functions of CD4+ and CD8+ T lymphocytes, J Immunol, 177, 4962, 10.4049/jimmunol.177.8.4962 Scott, 2003, A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer, Clin Cancer Res, 9, 1639 Narra, 2007, Phase II trial of single agent Val-boroPro (Talabostat) inhibiting hibroblast activation protein in patients with metastatic colorectal cancer, Cancer Biol Ther, 6, 1691, 10.4161/cbt.6.11.4874 Prieto, 2012, CTLA-4 blockade with ipilimumab: long-term follow-up of 177 patients with metastatic melanoma, Clin Cancer Res, 18, 2039, 10.1158/1078-0432.CCR-11-1823 Wolchok, 2013, Nivolumab plus ipilimumab in advanced melanoma, N Engl J Med, 369, 122, 10.1056/NEJMoa1302369 Hamid, 2013, Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma, N Engl J Med, 369, 134, 10.1056/NEJMoa1305133 Feig, 2013, Targeting CXCL12 from FAP-expressing carcinoma- associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer, Proceedings of the National Academy of Sciences, 110, 20212, 10.1073/pnas.1320318110